sLV5FU2 (split-dose leucovorin + 5-fluorouracil)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for sLV5FU2 (split-dose leucovorin + 5-fluorouracil), covering 2017-01-31 to 2017-01-31. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy of ABI-007 Plus Gemcitabine or sLV5FU2 as First-line Therapy in Patients With Metastatic Pancreatic Cancer [Phase 2]